Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
2011-1-3
pubmed:abstractText
The purpose of this study was to elucidate the treatment efficacy and safety of gemcitabine monotherapy, and to identify prognostic factors in patients with advanced biliary tract cancer receiving this therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1423-0232
pubmed:author
pubmed:copyrightInfo
Copyright © 2010 S. Karger AG, Basel.
pubmed:issnType
Electronic
pubmed:volume
79
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
39-45
pubmed:meshHeading
pubmed-meshheading:21063134-Adult, pubmed-meshheading:21063134-Aged, pubmed-meshheading:21063134-Aged, 80 and over, pubmed-meshheading:21063134-Analysis of Variance, pubmed-meshheading:21063134-Antimetabolites, Antineoplastic, pubmed-meshheading:21063134-Biliary Tract Neoplasms, pubmed-meshheading:21063134-C-Reactive Protein, pubmed-meshheading:21063134-Carcinoembryonic Antigen, pubmed-meshheading:21063134-Deoxycytidine, pubmed-meshheading:21063134-Disease-Free Survival, pubmed-meshheading:21063134-Female, pubmed-meshheading:21063134-Humans, pubmed-meshheading:21063134-Male, pubmed-meshheading:21063134-Middle Aged, pubmed-meshheading:21063134-Neoplasm Staging, pubmed-meshheading:21063134-Predictive Value of Tests, pubmed-meshheading:21063134-Prognosis, pubmed-meshheading:21063134-Retrospective Studies, pubmed-meshheading:21063134-Serum Albumin, pubmed-meshheading:21063134-Treatment Outcome, pubmed-meshheading:21063134-Tumor Markers, Biological
pubmed:year
2010
pubmed:articleTitle
Treatment efficacy/safety and prognostic factors in patients with advanced biliary tract cancer receiving gemcitabine monotherapy: an analysis of 100 cases.
pubmed:affiliation
Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan. eisuzuki@ks.kyorin-u.ac.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't